Product
ORC-13661
1 clinical trial
2 indications
Indication
OtotoxicityIndication
Drug-inducedClinical trial
Phase 2 Study of the Efficacy and Safety of ORC-13661 for the Prevention of Drug-Induced Hearing Loss in Patients Receiving Intravenous Amikacin for Treatment of Non-Tuberculous Mycobacterium DiseaseStatus: Not yet recruiting, Estimated PCD: 2027-01-01